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expression, location and function
Cameron M Smith1, Michael Z Michael2,3, David I Watson1,3, Grace Tan1, David St J Astill3,4, Richard Hummel1
and Damian J Hussey1,3*Abstract
Background: Ulceration of the oesophageal squamous mucosa (ulcerative oesophagitis) is a pathological
manifestation of gastro-oesophageal reflux disease, and is a major risk factor for the development of Barrett’s
oesophagus. Barrett’s oesophagus is characterised by replacement of reflux-damaged oesophageal squamous
epithelium with a columnar intestinal-like epithelium. We previously reported discovery of microRNAs that are
differentially expressed between oesophageal squamous mucosa and Barrett’s oesophagus mucosa. Now, to better
understand early steps in the initiation of Barrett’s oesophagus, we assessed the expression, location and function
of these microRNAs in oesophageal squamous mucosa from individuals with ulcerative oesophagitis.
Methods: Quantitative real-time PCR was used to compare miR-21, 143, 145, 194, 203, 205 and 215 expression
levels in oesophageal mucosa from individuals without pathological gastro-oesophageal reflux to individuals with
ulcerative oesophagitis. Correlations between microRNA expression and messenger RNA differentiation markers
BMP-4, CK8 and CK14 were analyzed. The cellular localisation of microRNAs within the oesophageal mucosa was
determined using in-situ hybridisation. microRNA involvement in proliferation and apoptosis was assessed following
transfection of a human squamous oesophageal mucosal cell line (Het-1A).
Results: miR-143, miR-145 and miR-205 levels were significantly higher in gastro-oesophageal reflux compared with
controls. Elevated miR-143 expression correlated with BMP-4 and CK8 expression, and elevated miR-205 expression
correlated negatively with CK14 expression. Endogenous miR-143, miR-145 and miR-205 expression was localised to
the basal layer of the oesophageal epithelium. Transfection of miR-143, 145 and 205 mimics into Het-1A cells
resulted in increased apoptosis and decreased proliferation.
Conclusions: Elevated miR-143, miR-145 and miR-205 expression was observed in oesophageal squamous mucosa
of individuals with ulcerative oesophagitis. These miRNAs localised to the basal layer of the oesophageal
epithelium. They reduced proliferation and increased apoptosis, and may play roles in regulating epithelial
restoration in response to injury caused by gastro-oesophageal reflux.
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Gastro-oesophageal reflux disease affects up to 50% of
Western populations [1]. Gastric physiology offers pro-
tection from exposure to acid and bile, although the
oesophageal lumen is largely unprotected, lacking an
adherent mucous barrier [2]. Patients with chronic reflux
can present with endoscopically visible mucosal damage,
and this manifests as mucosal ulceration (ulcerative
oesophagitis) [1]. At the cellular level, ulcerative
oesophagitis is associated with increased cell prolifera-
tion [3] and apoptosis [4]. Increased inflammatory cell in-
filtrate [5] and hyper-proliferation of basal cells are typical
histopathological changes associated with gastro-
oesophageal reflux [3,6]. We have shown previously that
increases in cytokeratin (CK) 14 messenger RNA (mRNA)
levels correlate with increased severity of reflux [1]. This
appears to be a molecular marker of basal cell hyperplasia.
Ulcerative oesophagitis is a major independent risk fac-
tor for the development of Barrett’s oesophagus [7], which
is characterised by a metaplastic transition from normal
oesophageal squamous epithelium to a columnar epithe-
lium with intestinal features [2]. Barrett’s oesophagus is
associated with a 40 fold increase in the risk of develo-
ping oesophageal adenocarcinoma, a cancer with poor
prognosis [8]. Although Barrett’s oesophagus is not a can-
cerous lesion, the increased risk of cancer development
it carries means that investigating markers associated
with the development of Barrett’s oesophagus is worth-
while. Studying gene expression in squamous epithelium
that has been exposed to reflux might identify changes
that precede progression to Barrett’s oesophagus. Previous
reports have shown increased expression of the BMP-4
gene, in squamous oesophageal epithelium from indivi-
duals with ulcerative oesophagitis [9]. Further, reflux
induced expression of BMP-4 has been shown to induce
a shift from a squamous to a columnar gene expression
profile in oesophageal squamous cells [9,10]. This sug-
gests that reflux induced gene expression changes in
ulcerative oesophagitis may promote conversion from
squamous to columnar epithelium.
MicroRNAs (miRNAs) are small RNA molecules that
regulate gene expression [11]. Preliminary evidence
implicates miRNAs in the differentiation of intestinal
[12] and squamous epithelial cell phenotypes [13], and
cell proliferation and apoptosis [14]. We have identified
miRNAs that are differentially expressed in Barrett’s
oesophagus [15]. miR-203 and miR-205 are expressed
at higher levels in squamous mucosa, and miR-143,
miR-145, miR-194 and miR-215 are expressed at higher
levels in Barrett’s oesophagus. Currently, it is not known
whether miRNA expression is altered in gastro-oesophageal
reflux exposed squamous epithelium at risk of progressing
to Barrett’s oesophagus. If miRNA expression is altered in
the squamous epithelium of individuals with ulcerativeArchived at Flinders Universioesophagitis, then this might provide insight into the devel-
opment of Barrett’s oesophagus.
In this study we hypothesised that miR-203, 205, 143,
145, 194 and 215 expression might be altered in esopha-
geal squamous mucosa in response to chronic gastro-
oesophageal reflux. The aims of the study were to 1) Deter-
mine the expression of miRNAs known to be differentially
expressed between normal squamous and Barrett’s
oesophagus mucosa (miR-203, 205, 143, 145, 194 and 215)
in oesophageal squamous mucosa from individuals with
ulcerative oesophagitis; 2) Assess the location of miRNA
accumulation within the oesophageal epithelium; 3) Assess
the role of these miRNAs in regulating proliferation and
apoptosis, processes that contribute to tissue restoration in
reflux-damaged mucosa.Methods
Tissue collection and processing
Oesophageal mucosal fresh tissue biopsies were collected
from individuals undergoing upper gastrointestinal en-
doscopy. Full details of the tissue collection protocol
and RNA extraction procedure have been described
previously [1,15]. In the current study we used mucosal
biopsies collected from the oesophageal squamous mucosa
5 cm above the gastro-oesophageal junction from normal
subjects and from subjects with gastro-oesophageal reflux
with ulcerative oesophagitis. Normal subjects without cli-
nical or endoscopic evidence of gastro-oesophageal reflux
were used as the controls (n=13; median age 54 years). Selec-
tion criteria for controls were a visibly normal oesophageal
mucosa at endoscopy, no endoscopic indicators of mecha-
nical incompetence of the gastro-oesophageal junction, no
current or previous symptoms of gastro-oesophageal reflux
disease and no use of antisecretory medication. Subjects with
gastro-oesophageal reflux (n=10; median age 52 years) were
included if they had typical symptoms of gastro-oesophageal
reflux disease (heartburn and regurgitation), mucosal ulcer-
ation (Savary Miller grade I to IV) at endoscopy, and no
endoscopic or histological evidence of Barrett’s oesophagus.
The Flinders Clinical Research Ethics Committee approved
tissue collection.
Mucosal biopsies were collected and stored in RNAla-
terW (Ambion, Austin, Texas, USA) at −20°C. When
required, biopsies were thawed and a small piece of each
biopsy was fixed using formalin, embedded in paraffin for
histopathological confirmation of the tissue origin. RNA
was extracted from once thawed tissue using TRIzolW as
described previously [1]. RNA yield was determined
by spectrophotometry, and the quality assessed by
agarose gel electrophoresis. Oesophageal mucosal tis-
sue biopsies, used for in-situ hybridisation, were col-
lected adjacent to those used to assess miRNA and
mRNA expression by the same collection protocolty: dspace.flinders.edu.au
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with 10% formalin and subsequently embedded in paraffin.
miRNA and mRNA quantitation by real-time RT-PCR
Quantitative real-time PCR was used to measure miRNA
and mRNA expression levels in oesophageal mucosal
biopsies from individuals without pathological reflux and
individuals with ulcerative oesophagitis. The expression of
miRNAs in the different types of oesophageal squamous
mucosa was determined using previously described meth-
ods [15]. miR-21 (P/N# 4373090), miR-143 (P/N#
4373134), miR-145 (P/N# 4373133), miR-194 (P/N#
437310), miR-203 (P/N# 4373095), miR-205 (P/N#
4373093), miR-215 (P/N# 4373084) levels were deter-
mined by qRT-PCR using TaqManW miRNA assays
(Applied Biosystems, Foster City, California, USA). Due
to limited RNA, miR-145 expression was only assessed
in ten of the 13 controls. The levels of differentially
expressed miRNAs were correlated with the mRNA
expression levels of squamous (CK14) and columnar
(CK8 and BMP-4) differentiation markers in squamous
mucosa from patients with gastro-oesophageal reflux.
mRNA levels were assessed using a QuantiscriptW RT
kit for reverse transcription and the QuantitectW SYBR-
Green mastermix for PCR (Qiagen, Valencia, California).
Primer details are available upon request. miRNA expres-
sion was normalised to U44 small nucleolar RNA levels
(P/N# 4373384) and mRNA expression was normalised to
ß-actin levels.
In-Situ Hybridisation (ISH)
To localise miRNA activity within the oesophageal mu-
cosa in-situ hybridisation was performed, probing against
miRNAs elevated in ulcerative oesophagitis. Standard
hematoxylin and eosin (H&E) staining was performed to
confirm the tissue type. In-situ hybridisation was per-
formed on serial 4 μm sections of 4% formalin fixed, paraf-
fin embedded oesophageal tissue biopsies from controls
and individuals with ulcerative oesophagitis. The in-situ
hybridisation protocol was based on a protocol published
by Pena and colleagues [16] with the following changes.
All buffers were prepared with diethyl pyrocarbonate
(DEPC) treated water (Sigma, Castle Hill, NSW) unless
otherwise stated. Sections were deparaffinised in Histo-
Clear (National Diagnostics, Atlanta, Georgia) and rehy-
drated through an ethanol dilution series (100-25%). Slides
were then washed for 5 min in water treated with DEPC
followed by 13 min in 2 μg/ml proteinase K treatment
(Roche Diagnostics, Mannheim, Germany). Tissue sec-
tions were acetylated for 10 min and then washed twice,
for five minutes in PBS. Sections were framed with a wax
pen (Vector Laboratories, Burlingame, California), covered
with 40 μl of pre-hybridisation solution [16] and incubated
at room temperature for four hours. Pre-hybridisationArchived at Flinders Universibuffer was tipped from the slides and replaced with 40 μl
of either the digoxigenin (DIG)-labeled, Locked Nucleic
Acid (LNA)-miRNA probe or LNA-scramble probe
(Exiqon, Vedbaek, Denmark) diluted to 250 nM with
denaturing hybridisation buffer (0.25% CHAPS (Amresco,
Solon #0465-5g), 0.1% Tween-20 (Sigma-Aldrich, St
Louis, MO, USA #P1379). Slides were then incubated at
55°C overnight. The LNA-probes used include miR-143
(#38515-15), miR-145 (#38517-15), miR-205 (#18099-15)
and miR-SCR (#99004-15). The sequence of the miR-SCR
duplex, used as a negative control, shared no homology
with known miRNAs.
Slides were washed twice with 0.2X SSC buffer heated
to 60°C and then incubated with 0.2X SSC buffer 60 min
at 60°C. Levamisole (24% w/v) (Sigma Aldrich, St Louis,
Mo, USA, #L9756-5G) was used to reduce background
alkaline phosphate activity. Slides were submerged in
levamisole buffer containing 1M TRIS pH 7.5 and 5M
NaCl for 5 min at room temperature. The sections were
then incubated with a blocking buffer (1% blocking buf-
fer and 1X maleic acid buffer, DIG Wash and Block Buf-
fer Set, (Roche Diagnostics, Mannheim, Germany) for 60
min. 40 μl of anti-DIG antibodies (Roche Diagnostics,
Mannheim, Germany) diluted 1:2000 using blocking
buffer was added to each section and then slides were
incubated overnight at 4°C. The slides were then washed
in 1X wash buffer (DIG Wash and Block Buffer Set,
Roche Diagnostics, Mannheim, Germany) and incubated
with the detection buffer (0.08 M Tris-Cl containing
0.17 M NaCl pH 9.5) for 10 min. The slides were then
submerged in a 1:500 dilution of nitro blue tetrazolium
chloride (NBT) /BCIP (5-bromo-4-chloro-3-indolyl phos-
phate, toluidine salt) (Roche Diagnostics, Mannheim,
Germany) until staining was observed. Buffered glycerol
was added to each section before cover-slipping.
Het-1A Cell Culture and miRNA over-expression
To assess the impact of selected miRNAs on prolifera-
tion and apoptosis in oesophageal epithelial cells miR-
143, miR-145 or miR-205 were overexpressed in Het-1A
cells, a non-neoplastic oesophageal keratinocyte derived
cell line [1,17]. Het-1A cells were cultured using LHC-9
medium (Invitrogen, Mulgrave, Victoria). Cells were
transfected with either miR-143, miR-145 or miR-205
mimics or a negative control duplex. Experiments meas-
uring cell proliferation were conducted using 96 well
plates. Three thousand Het-1A cells were plated per well
and 10 wells were used for each experimental and
control group. Experiments measuring apoptosis were
conducted using 24 well plates, 50,000 Het-1A cells were
plated per well and 8 wells were used for each experi-
mental and control group.
miRNA levels were increased by transfecting cells with
miR-143, miR-145 or miR-205 mimics using thety: dspace.flinders.edu.au
Table 1 MiRNA expression in oesophageal squamous
mucosa from subjects with ulcerative oesophagitis vs
controls without gastro-oesophageal reflux disease
Controls (n=13) Reflux (n=10) P-value
miR-143 0.000157 0.000361 0.0101
(0.000171, 0.000317) (0.000160, 0.00130)
miR-145 0.00846 0.0177 0.0115
(0.00458, 0.0101) (0.00956, 0.0363)
miR-205 0.6721 1.73 0.0026
(0.481, 1.061) (1.31, 2.54)
miR-21 0.604 0.459 0.7133
(0.304, 0.977) (0.233, 1.25)
miR-194 0.000138 0.000134 0.9705
(0.000101, 0.000213) (9.77-05, 0.000238)
miR-203 0.169 0.27 0.1138
(0.135, 0.265) (0.206, 0.336)
miR-215 5.99-05 5.45-05 0.7132
(−0.000180, 0.000716) (3.63-5, 0.000128)
Relative expression values are expressed as median (95% confidence intervals).
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Victoria) as per the manufacturer’s protocol. Cells were
transfected using miRNA mimic or negative control
duplexes at 33 nM concentration (miR-143 #2988, miR-
145 #8480, miR-205 #3391, negative control duplex
#1733 all from GenePharma, Shanghai, China).
Cell proliferation and apoptosis were assayed, and
miRNA over-expression was confirmed 24 and 48 h post
transfection. Cell numbers were measured using the
MTS assay system (Invitrogen, Mulgrave, Victoria) as
per the manufacturer’s protocol. Cell numbers at each
time point were assessed to compare cell groups trans-
fected with either miR-143, miR-145 or miR-205 with
cells transfected with the negative control duplex.
Apoptosis was measured by assessing the numbers of
pre-apoptotic cells. The annexinV antibody (BD Bios-
ciences, North Ryde, NSW) was used with propidium
iodide as per the manufacturer’s protocol to stain viable,
pre-apoptotic, and non-viable cells 24 and 48 h post-
transfection. Propidium iodide indicated cell viability
and positive AnnexinV, pre-apoptotic staining was mea-
sured using flow cytometry (BD FACSCANTO II, BD
Biosciences, North Ryde, NSW) and the BD FACSDiva
software package. In addition RNA was extracted from
the transfected cells using TRIzolW, and miR-143, miR-
145 and miR-205 levels were assessed in transfected cell
lines using the methods described above.
Statistical analysis
miRNA and mRNA expression data were analysed using
Q-Gene software [18]. Gene expression data were tested
for normality using the Shapiro-Wilk test. Differences in
miRNA expression between tissues were assessed for
statistical significance using the Mann–Whitney test
(GraphPad Prism Software, Inc. La Jolla, CA, USA).
Spearman rank order correlation tests between miRNA
vs. mRNA expression in tissues were determined on-line
(http://www.wessa.net/rankcorr.wasp). Differences in prolif-
eration and apoptosis in the Het-1A cell line were assessed
using the Mann–Whitney test.
Results
miRNA expression and mRNA expression in tissues
Table 1 summarises the expression of the evaluated
miRNA markers. The expression of miR-143, miR-145,
and miR-205 were significantly higher in oesophageal
squamous mucosa from subjects with ulcerative
oesophagitis compared to squamous mucosa from sub-
jects without pathological reflux. There were no signifi-
cant differences between the 2 groups of squamous
mucosae for the expression of miR-21, miR-194, miR-
203 and miR-215.
In oesophageal squamous mucosa biopsies from indivi-
duals with ulcerative oesophagitis, there were significantArchived at Flinders Universipositive correlations between the expression of miR-143
and CK8 (Rho = 0.802, p = 0.004), miR-143 and BMP-4
(Rho = 0.591, p = 0.032), and a significant negative
correlation between miR-205 and CK14 (Rho = −0.587,
p = 0.034).
Spatial expression of miR-143, miR-145 and miR-205 in
oesophageal biopsies
In situ hybridisation was used to study the spatial expres-
sion of miRNAs in oesophageal tissues. In oesophageal
mucosal biopsies from individuals with ulcerative
oesophagitis, the expression of miR-143, miR-145 and
miR-205 was predominantly most intense in the basal
layer of the epithelium (Figure 1). Haematoxylin and eosin
stained sections showed elongated papillae and an
enlarged basal layer, consistent with known gastro-
oesophageal reflux histopathology (Figure 1A). Staining
for miR-143 (Figure 1B), miR-145 (Figure 1C) and miR-
205 probes (Figure 1D) revealed similar expression pat-
terns, with the most intense staining seen in the basal
layer of the epithelium. Staining of both the cytoplasm
and nucleus was seen, with greater staining intensity seen
within the nucleus in most cells. No staining was observed
with the negative control duplex (Figure 1E).
Increasing miR-143, miR-145 and miR-205 activity in Het-
1A cells
To address the roles of the three differentially expressed
miRNAs, synthetic miRNA mimics were transfected into
the oesophageal keratinocyte cell line, Het-1A, to deter-
mine their effect on proliferation and apoptosis. The me-
dian fold increase in miR-143, miR-145 and miR-205
levels, 24 hours after transfection, is presented inty: dspace.flinders.edu.au
Figure 1 (See legend on next page.)
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Figure 1 miRNA in situ hybridisation analysis in oesophageal mucosal biopsies from patients with ulcerative oesophagitis. A: Staining
with Haematoxylin and Eosin. The basal layer, papillae and differentiated squamous epithelium are clearly visible. B, C, D and E: Hybridisation with
LNA-probes for miRNAs miR-143 (B), miR-145 (C) and miR-205 (D), and LNA-negative control (E). No hybridisation was observed with the LNA-
negative control probe. A region from each section has been magnified 100x. In A, rounded nuclei in the oesophageal epithelium are evident.
B, C & D depict the punctate nuclear staining observed for each miRNA.
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miR-143, miR-145 or miR-205 activity in the Het-1A cell
line. Elevated miRNA levels were associated with signifi-
cantly decreased proliferation and significantly increased
apoptosis.
Discussion
miRNA regulation of gene expression has been impli-
cated in most cellular processes [11], and it probably
plays a role in the development of Barrett’s oesophagus.
miRNA expression patterns might be useful biomarkers
for the clinical assessment and management of Barrett’s
oesophagus. Previous work from our laboratory which
compared normal squamous oesophageal mucosa with
Barrett’s oesophagus showed increased expression of
miR-21, miR-143, miR-145, miR-194 and miR-215, and
decreased expression of miR-203 and miR-205 in
Barrett’s oesophagus. Ulcerative oesophagitis of the squa-
mous mucosa, secondary to gastro-oesophageal reflux, has
been shown to pre-dispose to the development of Barrett’s
oesophagus [7]. Therefore, in the current study miRNAsFigure 2 Normalised median fold increase in miR-143, miR-145
and miR-205 levels at 24 hours after transfection with
respective mimics. The fold increase in miRNA levels was
calculated as the ratio of miRNA expression in Het-1A cells
transfected with a miRNA mimic compared with miRNA expression
in Het-1A cells transfected with the negative control duplex.
Archived at Flinders Universiassociated with metaplasia were investigated in the earlier
context of ulcerative oesophagitis.
Our study demonstrated elevated miR-143 and miR-145
levels in the oesophageal squamous mucosa from sub-
jects with ulcerative oesophagitis (and without Barrett’sFigure 3 Cell proliferation (A) and apoptosis (B) levels in Het-
1A cells 48 h after transfection with miR-143, miR-145 or miR-
205. Data are represented as a percentage of the negative control.
Decreased proliferation (A) and increased apoptosis (B) were
observed for all miRNAs. For all negative control vs miRNA mimic
comparisons p<0.05 (Mann–Whitney test).
ty: dspace.flinders.edu.au
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oesophageal reflux disease. This extends our previous
observation of elevated miR-143 and miR-145 expres-
sion in Barrett’s oesophagus epithelium [15], and sug-
gests that increased expression of these miRNAs occurs
prior to the development of Barrett’s oesophagus. In
support of the proposal that alterations in miR-143 and
miR-145 expression occur at an early stage in the develop-
ment of Barrett’s oesophagus, we also observed positive cor-
relations in expression between miR-143 and CK8, and
miR-143 and BMP-4, in the oesophageal mucosa from indi-
viduals with ulcerative oesophagitis. The BMP-4 pathway is
activated in the oesophageal mucosa in both ulcerative
oesophagitis and Barrett’s oesophagus, and this promotes
expression of columnar gene markers [9]. Further, CK8 is a
known marker of columnar epithelia [19]. Taken together,
these correlations with BMP-4 and CK8 support an associ-
ation between elevated miR-143 expression and elevated
expression of columnar cell markers in reflux-exposed
squamous mucosa. Whether or not miR-143 has a role in
modulating gene expression programs to promote meta-
plastic conversion of a squamous to a columnar mucosa
remains undetermined.
Although we observed upregulation of miR-143 and
miR-145 in squamous mucosa from individuals with ul-
cerative oesophagitis, we did not observe altered expres-
sion of other miRNAs, miR-21, miR-194 and miR-215,
which have previously been shown to be increased in
Barrett’s oesophagus mucosa. However, support for the
argument that miR-143 and miR-145 might have a role
in promoting the development of Barrett’s oesophagus
does not actually require the expression of other colum-
nar miRNAs to be altered in our current study. It is
important to note that the current study evaluated
oesophageal squamous mucosa from individuals with
ulcerative oesophagitis, and none of these individuals
had Barrett’s oesophagus. Our negative findings for miR-
21/194/215 are consistent with the upregulation of these
miRNAs occuring later in the progression to Barrett’s
oesophagus.
Two major hallmarks of oesophageal squamous mucosa
in the presence of ulcerative oesophagitis include increased
proliferation and apoptosis [1,3,4]. We sought to identify
the spatial expression of miR-143, miR-145 and miR-205.
Also, given the known association of these miRNAs with
proliferation and apoptosis, we assessed possible roles in a
squamous oesophageal cell line [17]. We observed reduced
proliferation and increased apoptosis in the cells following
transfection with miR-143, miR-145 and miR-205 mimics.
Restoring miR-143, miR-145 or miR-205 expression in
other cell models has also been shown to reduce cell
proliferation and increase apoptosis [20-24]. In ulcerative
oesophagitis miR-143, miR-145 and miR-205 staining inten-
sity was greatest in the basal layer of the oesophagealArchived at Flinders Universiepithelium, and it is possible that these miRNAs might dir-
ect anti-proliferative and pro-apoptotic effects within this
layer. The pro-apoptotic effects of transfection with miR-
143, miR-145 or miR-205 mimics may reflect the physio-
logical apoptotic response observed in the oesophagus fol-
lowing reflux exposure. It is possible that up-regulation of
miR-143, miR-145 or miR-205, and the associated anti-
proliferative effect, might counterbalance hyperplasia in the
basal layer of the oesophageal epithelium. In support of this,
we identified an inverse correlation between miR-205 and
CK14, a marker of basal cell hyperplasia and squamous res-
toration. Taken together, these results suggest that miR-143,
miR-145 and miR-205 might suppress proliferation or pro-
mote apoptosis in the basal layer of the oesophageal epithe-
lium. These miRNAs could be informative in studies that
compare the efficacy of different treatment methods used
for controlling gastro-oesophageal reflux.
Very recently, van Baal and colleagues reported that
forced expression of miR-145 in Het-1A squamous
oesophageal cells results in reduced cell counts and
reduced expression of proliferating cell nuclear antigen
[25]. However, apoptosis was not assessed in this study,
and human tissues from reflux oesophagitis patients with-
out Barrett’s oesophagus were not evaluated. Our data are
consistent with the reported anti-proliferative effect of
miR-145, and in addition, demonstrate apoptotic induction
as a miR-145 mediated process in oesophageal squamous
cells. Interestingly, this group also showed that miR-145
can modulate BMP-4 expression and alter BMP-4 signal-
ling in Het-1A cells, thus providing in-vitro data suggestive
of a role for miR-145 in regulating squamous to columnar
cell differentiation. Taken together with our in-vivo obser-
vations of elevated levels of miR-145 in squamous
oesophageal mucosa from individuals with ulcerative
oesophagitis, the data suggest that miRNAs have a real
functional role in controlling cellular identity in
oesophageal mucosa in the setting of gastro-oesophageal
reflux. It is possible that gastro-oesophageal reflux alters
the expression of several miRNAs, including those identi-
fied in our study, in oesophageal squamous mucosa. These
miRNAs could target genes and pathways that contribute
to columnar metaplasia, and if enough alterations are
induced this might promote the formation of Barrett’s
oesophagus mucosa. Future studies could explore the miR-
NAs and miRNA targets involved, and use model systems
to determine whether induction of a switch from squa-
mous to Barrett’s mucosa is possible. Any model should
combine both stromal and epithelial components of the
oesophageal mucosa in order to faithfully replicate the
complexity of cell types and signalling that is thought to be
involved in Barrett’s oesophagus development [9].
In-situ hybridisation staining for miR-143, miR-145
and miR-205 appeared to be both nuclear and cytoplas-
mic. Nuclear staining has been reported for miR-145ty: dspace.flinders.edu.au
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to show nuclear staining for miR-143, miR-145 and
miR-205 in the oesophagus. Nuclear localisation of
mature miRNAs is surprising, as they are typically
known to exert their effects in the cytoplasm. However,
recent studies also describe the nuclear localisation of
mature miRNAs [27,28] and suggest that nuclear
miRNAs can direct biological processes [29]. There-
fore miR-143, miR-145 and miR-205 may regulate
gene expression in the nucleus of oesophageal epithe-
lial cells to exert the effects observed in our study.
Our study has some limitations. Firstly, our sample
cohort was of modest size and we were not able to com-
pare differences in miRNA expression between genders.
Further validation in a larger cohort may help to identify
differences in miRNA expression between genders, and
may help explain why males are more likely to develop
Barrett’s oesophagus than females [30]. Secondly, we
limited our study to the miRNAs shown by Wijnhoven
et al. [15] to be differentially expressed between normal
squamous epithelia and Barrett’s oesophagus. As global
miRNA expression changes were not assessed it is pos-
sible that the expression of other miRNAs may be
altered in response to chronic reflux. Thirdly, we used a
common transfection protocol to increase miRNA levels
in Het-1A cells greater than physiological miRNA levels.
This may impact on the biological relevance. However,
all assay results were compared with Het-1A cells trans-
fected with a negative control duplex at similar levels.
Conclusions
We have shown that miRNA expression is altered in the
oesophageal squamous mucosa from individuals with
gastro-oesophageal reflux and ulcerative oesophagitis.
These changes in miR-143, miR-145 and miR-205 ex-
pression appear to be most pronounced in the basal
layer of the oesophageal epithelium. In the context of
gastro-oesophageal reflux these expression changes
might influence proliferation and apoptosis and thereby
regulate epithelial restoration. It is reasonable to hypothe-
sise that they could represent early molecular events pre-
ceding the development of Barrett’s oesophagus, although
proving this will require further studies as described
above. Future detailed analyses of the role of these miR-
NAs in progression from gastro-oesophageal reflux to
Barrett’s oesophagus, and then to oesophageal adenocar-
cinoma will be valuable, and may help in efforts to control
and treat these diseases.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
CMS: performed the qRT-PCR miRNA experiments, performed the in-situ
hybridisation experiment, and performed the cell transfection, proliferation
and apoptosis assays; MZM: assisted with in-situ hybridisation and miRNAArchived at Flinders Universiexpression protocols and analyses; DIW: collection of samples; GT: assisted
with sample processing and performed qRT-PCR analysis of mRNA
expression; DStJA: histopathological confirmation and assessment of in-situ
miRNA localisation in tissues; RH: assisted with proliferation and apoptosis
experimental protocols and conducting miRNA qRT-PCR analysis; DJH:
supervision of the study. CMS, MZM, DIW and DJH had lead roles in
manuscript preparation, and all authors read and approved the final
manuscript.
This study was funded by a Competing Project Grant from the National
Health and Medical Research Council of Australia. Cameron Smith was
supported by a PROBE-NET PhD scholarship funded by a Strategic research
Partnerships Grant from the Cancer Council of New South Wales.
Acknowledgments
We thank staff in Anatomical Pathology at SA Pathology, Flinders Medical
Centre for assistance with tissue processing and staining of tissue slides.
Author details
1Department of Surgery, Flinders University, Room 3D213, Flinders Medical
Centre, Bedford Park, South Australia 5042, Australia. 2Department of
Gastroenterology & Hepatology, Flinders University, Bedford Park, South
Australia, Australia. 3Flinders Centre for Cancer Prevention and Control,
Flinders University, Bedford Park, South Australia, Australia. 4Department of
Anatomical Pathology, Flinders Medical Centre, Bedford Park, South Australia
5042, Australia.
Received: 18 August 2012 Accepted: 4 January 2013
Published: 8 January 2013
References
1. van Roon AH, Mayne GC, Wijnhoven BP, et al: Impact of gastro-
oesophageal reflux on mucin mRNA expression in the oesophageal
mucosa. J Gastrointest Surg 2008, 12:1331–1340.
2. Dixon J, Strugala V, Griffin SM, et al: Oesophageal mucin: an adherent
mucus gel barrier is absent in the normal oesophagus but present in
columnar-lined Barrett's oesophagus. Am J Gastroenterol 2001,
96:2575–2583.
3. Mulder DJ, Pacheco I, Hurlbut DJ, et al: FGF9-induced proliferative
response to eosinophilic inflammation in oesophagitis. Gut 2009,
58:166–173.
4. Wetscher GJ, Schwelberger H, Unger A, et al: Reflux-induced apoptosis of
the oesophageal mucosa is inhibited in Barrett's epithelium. Am J Surg
1998, 176:569–573.
5. Moons LMG, Kusters JG, Van Delft JHM, et al: A pro-inflammatory
genotype predisposes to Barrett's oesophagus. Carcinogenesis 2008,
29:926–931.
6. Binato M, Fagundes R, Gurski R, Meurer L, Edelweiss MI:
Immunohistochemical overexpression of the p53 protein and Ki-67
(MIB-1) antigen in patients with GERD and chronic oesophagitis. Appl
Immunohistochem Mol Morphol 2010, 18:236–243.
7. Ronkainen J, Talley NJ, Storskrubb T, et al: Erosive oesophagitis is a risk
factor for Barrett's oesophagus: a community-based endoscopic follow-
up study. Am J Gastroenterol 2011, 106:1946–1952.
8. Pera M, Cameron AJ, Trastek VF, Carpenter HA, Zinsmeister AR: Increasing
incidence of adenocarcinoma of the oesophagus and oesophagogastric
junction. Gastroenterology 1993, 104:510–513.
9. Milano F, van Baal JW, Buttar N, et al: Bone morphogenetic protein 4
expressed in oesophagitis induces a columnar phenotype in
oesophageal squamous cells. Gastroenterology 2007, 132:2412–2421.
10. Zhou G, Sun YG, Wang HB, et al: Acid and bile salt up-regulate BMP4
expression in human oesophageal epithelium cells. Scand J Gastroenterol
2009, 44:926–932.
11. Pillai R, Bhattacharyya S, Filipowicz W: Repression of protein synthesis by
miRNAs: how many mechanisms? Trends Cell Biol 2007, 17:118–126.
12. Dalmasso G, Thu Nguyen HT, Yan Y, et al: MicroRNAs determine human
intestinal epithelial cell fate. Differentiation 2010, 80:147–154.
13. Lena AM, Shalom-Feuerstein R, Di Val Cervo PR, et al: miR-203 represses
‘stemness’ by repressing ΔNp63. Cell Death Differ 2008, 15:1187–1195.
14. Sotiropoulou G, Pampalakis G, Lianidou E, Mourelatos Z: Emerging roles of
microRNAs as molecular switches in the integrated circuit of the cancer
cell. RNA 2009, 15:1443–1461.ty: dspace.flinders.edu.au
Smith et al. BMC Gastroenterology 2013, 13:4 Page 9 of 9
http://www.biomedcentral.com/1471-230X/13/415. Wijnhoven BP, Hussey DJ, Watson DI, Tsykin A, Smith CM, Michael MZ:
MicroRNA profiling of Barrett's oesophagus and oesophageal
adenocarcinoma. Br J Surg 2010, 97:853–861.
16. Pena JTG, Sohn-Lee C, Rouhanifard SH, et al: miRNA in situ hybridisation in
formaldehyde and EDC–fixed tissues. Nat Methods 2009, 6:139–141.
17. Stoner GD, Kaighn ME, Reddel RR, et al: Establishment and
characterization of SV40 T-antigen immortalized human oesophageal
epithelial cells. Cancer Res 1991, 51:365–371.
18. Simon P: Q-Gene: processing quantitative real-time RT-PCR data.
Bioinformatics 2003, 19:1439–1440.
19. van Baal JW, Bozikas A, Pronk R, et al: Cytokeratin and CDX-2 expression in
Barrett's oesophagus. Scand J Gastroenterol 2008, 43:132–140.
20. Wu H, Zhu S, Mo YY: Suppression of cell growth and invasion by miR-205
in breast cancer. Cell Res 2009, 19:439–448.
21. Takagi T, Iio A, Nakagawa Y, Naoe T, Tanigawa N, Akao Y: Decreased
expression of microRNA-143 and −145 in human gastric cancers.
Oncology 2009, 77:12–21.
22. Akao Y, Nakagawa Y, Iio A, Naoe T: Role of microRNA-143 in Fas-mediated
apoptosis in human T-cell leukemia Jurkat cells. Leuk Res 2009,
33:1530–1538.
23. Zaman MS, Chen Y, Deng G, et al: The functional significance of
microRNA-145 in prostate cancer. Br J Cancer 2010, 103:256–264.
24. Majid S, Dar AA, Saini S, et al: MicroRNA-205-directed transcriptional
activation of tumor suppressor genes in prostate cancer. Cancer 2010,
116:5637–5649.
25. van Baal JW, Verbeek RE, Bus P, et al: microRNA-145 in Barrett's
oesophagus: regulating BMP4 signalling via GATA6. Gut 2012,
Epub ahead of print.
26. Sempere L, Christensen M, Silahtaroglu A, et al: Altered MicroRNA
expression confined to specific epithelial cell subpopulations in breast
cancer. Cancer Res 2007, 67:11612–11620.
27. Hwang HW, Wentzel EA, Mendell JT: A hexanucleotide element directs
microRNA nuclear import. Science 2007, 315:97–100.
28. Liao JY, Ma LM, Guo YH, et al: Deep sequencing of human nuclear and
cytoplasmic small RNAs reveals an unexpectedly complex subcellular
distribution of miRNAs and tRNA 3' trailers. PLoS One 2010, 5:e10563.
29. Taft RJ, Simons C, Nahkuri S, et al: Nuclear-localised tiny RNAs are
associated with transcription initiation and splice sites in metazoans.
Nat Struct Mol Biol 2010, 17:1030–1034.
30. Caygill CP, Reed PI, Johnston BJ, Hill MJ, Ali MH, Levi S: A single centre's 20
years' experience of columnar-lined (Barrett's) oesophagus diagnosis.
Eur J Gastroenterol Hepatol 1999, 11:1355–1358.
doi:10.1186/1471-230X-13-4
Cite this article as: Smith et al.: Impact of gastro-oesophageal reflux on
microRNA expression, location and function. BMC Gastroenterology 2013
13:4.Archived at Flinders UniversiSubmit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submitty: dspace.flinders.edu.au
